Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MTOR | P42345 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | STAT6 | P42226 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | APLNR | P35414 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25117220 | 0.78 | SLC1A2 (0.43) | SLC1A2SLC1A1CYP2C19MAPK1LMNA | |
| SCHEMBL23662945 | 0.78 | SLC1A2 (0.43) | SLC1A2SLC1A1CYP2C19MAPK1LMNA | |
| SCHEMBL19066956 | 0.74 | ALDH1A1 (0.32) | SLC1A2SLC1A1ALDH1A1 | |
| SCHEMBL5428847 | 0.72 | MAPK1 (0.42) | SLC1A2SLC1A1CYP2C19MAPK1LMNA | |
| SCHEMBL10108095 | 0.72 | — | — | |
| SCHEMBL11499511 | 0.70 | SLC1A2 (0.47) | SLC1A2SLC1A1CYP2C19MAPK1LMNA | |
| SCHEMBL15746998 | 0.70 | HSD11B1 (0.41) | SLC1A2SLC1A1CYP2C19MAPK1LMNA | |
| SCHEMBL14389636 | 0.70 | HSD11B1 (0.41) | SLC1A2SLC1A1CYP2C19MAPK1LMNA | |
| SCHEMBL1108298 | 0.70 | HSD11B1 (0.41) | SLC1A2SLC1A1CYP2C19MAPK1LMNA | |
| SCHEMBL2897770 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2398758-A1 | REACTIVE EXTRACTION OF FREE ORGANIC ACIDS FROM AMMONIUM SALTS THEREOF | Evonik Degussa GmbH (DE) | 2011-12-28 | — | — | EP | claimed |
| WO-2010094630-A1 | REACTIVE EXTRACTION OF FREE ORGANIC ACIDS FROM AMMONIUM SALTS THEREOF | EVONIK DEGUSSA GMBH (DE) | 2010-08-26 | — | — | WO | claimed |
| US-20100210871-A1 | Reactive Extraction of Free Organic Acids from the Ammonium Salts Thereof | EVONIK DEGUSSA GMBH (DE) | 2010-08-19 | — | — | US | claimed |
| US-8809576-B2 | Method for producing a free acid from the salt thereof | EVONIK DEGUSSA GMBH (DE) | 2014-08-19 | — | — | US | disclosed |
| CN-102325746-A | Reactive Extraction of Free Organic Acids from Ammonium Salts of Organic Acids | EVONIK DEGUSSA GMBH | 2012-01-18 | — | — | CN | disclosed |
| EP-2398758-A1 | REACTIVE EXTRACTION OF FREE ORGANIC ACIDS FROM AMMONIUM SALTS THEREOF | Evonik Degussa GmbH (DE) | 2011-12-28 | — | — | EP | disclosed |
| CN-102272086-A | Method for producing a free acid from the salt thereof | — | 2011-12-07 | — | — | CN | disclosed |
| US-20110257429-A1 | METHOD FOR PRODUCING A FREE ACID FROM THE SALT THEREOF | EVONIK DEGUSSA GMBH (DE) | 2011-10-20 | — | — | US | disclosed |
| WO-2010094630-A1 | REACTIVE EXTRACTION OF FREE ORGANIC ACIDS FROM AMMONIUM SALTS THEREOF | EVONIK DEGUSSA GMBH (DE) | 2010-08-26 | — | — | WO | disclosed |
| US-20100210871-A1 | Reactive Extraction of Free Organic Acids from the Ammonium Salts Thereof | EVONIK DEGUSSA GMBH (DE) | 2010-08-19 | — | — | US | disclosed |
| EP-0504660-B1 | Liquid crystal compounds | BASF AG (DE) | 1998-08-19 | — | — | EP | disclosed |
| US-5549853-A | Linked azo dyes | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-27 | — | — | US | disclosed |
| US-5455325-A | Optically active phenoxypropionic esters | BASF AKTIENGESELLSCHAFT (DE) | 1995-10-03 | — | — | US | disclosed |
| US-5417882-A | Data carriers and display elements | BASF AKTIENGESELLSCHAFT (DE) | 1995-05-23 | — | — | US | disclosed |
| US-5417884-A | Containing a thiadiazole group | BASF AKTIENGESELLSCHAFT (DE) | 1995-05-23 | — | — | US | disclosed |
| EP-0630945-A1 | Use of reticulated azo dyes in non-linear optics | BASF Aktiengesellschaft (DE) | 1994-12-28 | — | — | EP | disclosed |
| US-5350873-A | Optically active phenoxypropionic esters | BASF AKTIENGESELLSCHAFT (DE) | 1994-09-27 | — | — | US | disclosed |
| EP-0583605-A1 | Defined oligomeric liquid crystalline compounds with smectic liquid crystalline phases | BASF Aktiengesellschaft (DE) | 1994-02-23 | — | — | EP | disclosed |
| EP-0528268-A2 | Optically active esters of phenoxypropionic acid | BASF Aktiengesellschaft (DE) | 1993-02-24 | — | — | EP | disclosed |
| EP-0504660-A2 | Liquid crystal compounds | BASF Aktiengesellschaft (DE) | 1992-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257429-A1 | METHOD FOR PRODUCING A FREE ACID FROM THE SALT THEREOF | FFAR1, SLC9B2, FFAR2 | SLC1A2 369/4885SLC1A1 411/4885CYP2C19 2213/4885 |
| US-20100210871-A1 | Reactive Extraction of Free Organic Acids from the Ammonium Salts Thereof | CA2, HCN2, CA9 | SLC1A2 321/4885SLC1A1 592/4885CYP2C19 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.